Bamco Inc. NY Has 971.67 Million Position in IDEXX Laboratories, Inc.
| IDXX Stock | USD 437.08 7.64 1.72% |
Slightly above 55% of IDEXX Laboratories' investor base is interested to short. The analysis of overall sentiment of trading IDEXX Laboratories stock suggests that many investors are impartial at this time. IDEXX Laboratories' investing sentiment can be driven by a variety of factors including economic data, IDEXX Laboratories' earnings reports, geopolitical events, and overall market trends.
IDEXX |
Bamco Inc. NY reduced its holdings in IDEXX Laboratories, Inc. by 5.5 percent during the third quarter, according to its most recent filing with the Securities and Exchange Commission . The institutional investor owned 1,923,258 shares of the companys stock after selling 112,079 shares during the quarter. IDEXX Laboratories accounts for 2.6 percent
Read at thelincolnianonline.com
 |
IDEXX Laboratories Current Investor Sentiment
Panic Vs Confidence
45
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use IDEXX Laboratories' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward IDEXX Laboratories.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
IDEXX Laboratories Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards IDEXX Laboratories can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
IDEXX Laboratories Historical Investor Sentiment
Investor biases related to IDEXX Laboratories' public news can be used to forecast risks associated with an investment in IDEXX. The trend in average sentiment can be used to explain how an investor holding IDEXX can time the market purely based on public headlines and social activities around IDEXX Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
IDEXX Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for IDEXX Laboratories and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average IDEXX Laboratories news discussions. The higher the estimate score, the more favorable the investor's outlook on IDEXX Laboratories.
IDEXX Laboratories Maximum Pain Price across 2024-12-20 Option Contracts
IDEXX Laboratories' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of IDEXX Laboratories close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of IDEXX Laboratories' options.
IDEXX Laboratories Fundamental Analysis
We analyze IDEXX Laboratories' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IDEXX Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IDEXX Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
IDEXX Laboratories is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
IDEXX Laboratories Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with IDEXX Laboratories stock to make a market-neutral strategy. Peer analysis of IDEXX Laboratories could also be used in its relative valuation, which is a method of valuing IDEXX Laboratories by comparing valuation metrics with similar companies.
Peers
IDEXX Laboratories Related Equities
| EXAS | EXACT Sciences | 2.57 | ||||
| CDNA | Caredx | 0.46 | ||||
| NTRA | Natera | 0.40 | ||||
| GH | Guardant Health | 0.37 | ||||
| MTD | Mettler Toledo | 0 | ||||
| CSTL | Castle Biosciences | 0.51 | ||||
| IQV | IQVIA Holdings | 1.05 | ||||
| PSNL | Personalis | 1.06 | ||||
| WAT | Waters | 1.30 | ||||
| ICLR | ICON PLC | 1.75 |
Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.